HMGB1 and cardiovascular disorder: Blocking HMGB1’s inflammatory signaling pathways holds promise as a novel therapeutic strategy for cardiovascular diseases, while modulating HMGA2 expression has the potential to delay disease progression by improving myocardial remodeling and repair processes (Zhang et al., 2021).